Xingda Zhang

Harbin, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications

iRGD-engineered exosomes mediate siMYC delivery for effective tumor suppression in triple-negative breast cancer.

iRGD-engineered exosomes mediate siMYC delivery for effective tumor suppression in triple-negative breast cancer.

Journal: Nanoscale
Published: December 12, 2025

Targeting the NAT10-HDAC4 positive feedback loop counteracts immunosuppression in breast cancer.

Targeting the NAT10-HDAC4 positive feedback loop counteracts immunosuppression in breast cancer.

Journal: Journal of experimental & clinical cancer research : CR
Published: October 04, 2025

Proteogenomic Characterization Reveals Subtype-Specific Therapeutic Potential for HER2-Low Breast Cancer.

Proteogenomic Characterization Reveals Subtype-Specific Therapeutic Potential for HER2-Low Breast Cancer.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: July 17, 2025

Personalized predictions of neoadjuvant chemotherapy response in breast cancer using machine learning and full-field digital mammography radiomics.

Personalized predictions of neoadjuvant chemotherapy response in breast cancer using machine learning and full-field digital mammography radiomics.

Journal: Frontiers in medicine
Published: February 24, 2025

Integrating ctDNA Dynamics and Sequential Organoid Drug Screening Enhances Breast Cancer Treatment Efficacy.

Integrating ctDNA Dynamics and Sequential Organoid Drug Screening Enhances Breast Cancer Treatment Efficacy.

Journal: Cancer research
Published: February 10, 2025

Developing and Evaluating a Nomogram Model Predicting Axillary Lymph Node Metastasis of Triple-Negative Breast Cancer Based on Multimodal Imaging Characteristics.

Developing and Evaluating a Nomogram Model Predicting Axillary Lymph Node Metastasis of Triple-Negative Breast Cancer Based on Multimodal Imaging Characteristics.

Journal: Academic radiology
Published: January 07, 2025

Metabolic reprogramming and therapeutic resistance in primary and metastatic breast cancer.

Metabolic reprogramming and therapeutic resistance in primary and metastatic breast cancer.

Journal: Molecular cancer
Published: September 30, 2024

FTO activates PD-L1 promotes immunosuppression in breast cancer via the m6A/YTHDF3/PDK1 axis under hypoxic conditions.

FTO activates PD-L1 promotes immunosuppression in breast cancer via the m6A/YTHDF3/PDK1 axis under hypoxic conditions.

Journal: Journal of advanced research
Published: September 14, 2024

PSAT1 Promotes Metastasis via p-AKT/SP1/ITGA2 Axis in Estrogen Receptor-Negative Breast Cancer Cell.

PSAT1 Promotes Metastasis via p-AKT/SP1/ITGA2 Axis in Estrogen Receptor-Negative Breast Cancer Cell.

Journal: Biomolecules
Published: June 25, 2024

An Approach for Differential Diagnosis of Breast Tumors by ctDNA Methylation Sequencing.

An Approach for Differential Diagnosis of Breast Tumors by ctDNA Methylation Sequencing.

Journal: Cancer medicine
Published: March 14, 2024

Precise subtyping reveals immune heterogeneity for hormone receptor-positive breast cancer.

Precise subtyping reveals immune heterogeneity for hormone receptor-positive breast cancer.

Journal: Computers in biology and medicine
Published: May 03, 2023

Revealing the Potential Markers of N(4)-Acetylcytidine through acRIP-seq in Triple-Negative Breast Cancer.

Revealing the Potential Markers of N(4)-Acetylcytidine through acRIP-seq in Triple-Negative Breast Cancer.

Journal: Genes
Published: October 28, 2022
Showing 1-12 of 23

Last Updated: 09/26/2026